318 related articles for article (PubMed ID: 21460210)
1. Glycomic analyses of mouse models of congenital muscular dystrophy.
Stalnaker SH; Aoki K; Lim JM; Porterfield M; Liu M; Satz JS; Buskirk S; Xiong Y; Zhang P; Campbell KP; Hu H; Live D; Tiemeyer M; Wells L
J Biol Chem; 2011 Jun; 286(24):21180-90. PubMed ID: 21460210
[TBL] [Abstract][Full Text] [Related]
2. Carbohydrate-binding domain of the POMGnT1 stem region modulates O-mannosylation sites of α-dystroglycan.
Kuwabara N; Manya H; Yamada T; Tateno H; Kanagawa M; Kobayashi K; Akasaka-Manya K; Hirose Y; Mizuno M; Ikeguchi M; Toda T; Hirabayashi J; Senda T; Endo T; Kato R
Proc Natl Acad Sci U S A; 2016 Aug; 113(33):9280-5. PubMed ID: 27493216
[TBL] [Abstract][Full Text] [Related]
3. Site mapping and characterization of O-glycan structures on alpha-dystroglycan isolated from rabbit skeletal muscle.
Stalnaker SH; Hashmi S; Lim JM; Aoki K; Porterfield M; Gutierrez-Sanchez G; Wheeler J; Ervasti JM; Bergmann C; Tiemeyer M; Wells L
J Biol Chem; 2010 Aug; 285(32):24882-91. PubMed ID: 20507986
[TBL] [Abstract][Full Text] [Related]
4. Glycosylation with ribitol-phosphate in mammals: New insights into the O-mannosyl glycan.
Manya H; Endo T
Biochim Biophys Acta Gen Subj; 2017 Oct; 1861(10):2462-2472. PubMed ID: 28711406
[TBL] [Abstract][Full Text] [Related]
5. Glycosyltransferase POMGNT1 deficiency strengthens N-cadherin-mediated cell-cell adhesion.
Noor SI; Hoffmann M; Rinis N; Bartels MF; Winterhalter PR; Hoelscher C; Hennig R; Himmelreich N; Thiel C; Ruppert T; Rapp E; Strahl S
J Biol Chem; 2021; 296():100433. PubMed ID: 33610554
[TBL] [Abstract][Full Text] [Related]
6. O-Mannosylation and human disease.
Dobson CM; Hempel SJ; Stalnaker SH; Stuart R; Wells L
Cell Mol Life Sci; 2013 Aug; 70(16):2849-57. PubMed ID: 23115008
[TBL] [Abstract][Full Text] [Related]
7. Neurons and glia modify receptor protein-tyrosine phosphatase ζ (RPTPζ)/phosphacan with cell-specific O-mannosyl glycans in the developing brain.
Dwyer CA; Katoh T; Tiemeyer M; Matthews RT
J Biol Chem; 2015 Apr; 290(16):10256-73. PubMed ID: 25737452
[TBL] [Abstract][Full Text] [Related]
8. [Finding of O-mannosyl glycan in mammals and congenital muscular dystrophies due to glycosylation defects].
Endo T
Yakugaku Zasshi; 2003 Oct; 123(10):825-35. PubMed ID: 14577328
[TBL] [Abstract][Full Text] [Related]
9. Recent advancements in understanding mammalian O-mannosylation.
Sheikh MO; Halmo SM; Wells L
Glycobiology; 2017 Sep; 27(9):806-819. PubMed ID: 28810660
[TBL] [Abstract][Full Text] [Related]
10. Glycobiology of α-dystroglycan and muscular dystrophy.
Endo T
J Biochem; 2015 Jan; 157(1):1-12. PubMed ID: 25381372
[TBL] [Abstract][Full Text] [Related]
11. Congenital muscular dystrophies involving the O-mannose pathway.
Martin PT
Curr Mol Med; 2007 Jun; 7(4):417-25. PubMed ID: 17584082
[TBL] [Abstract][Full Text] [Related]
12. Large induces functional glycans in an O-mannosylation dependent manner and targets GlcNAc terminals on alpha-dystroglycan.
Hu Y; Li ZF; Wu X; Lu Q
PLoS One; 2011 Feb; 6(2):e16866. PubMed ID: 21347376
[TBL] [Abstract][Full Text] [Related]
13. [Recent Advances in α-dystroglycanopathy].
Kuga A; Kanagawa M; Toda T
Brain Nerve; 2011 Nov; 63(11):1189-95. PubMed ID: 22068471
[TBL] [Abstract][Full Text] [Related]
14. Adeno-associated viral-mediated LARGE gene therapy rescues the muscular dystrophic phenotype in mouse models of dystroglycanopathy.
Yu M; He Y; Wang K; Zhang P; Zhang S; Hu H
Hum Gene Ther; 2013 Mar; 24(3):317-30. PubMed ID: 23379513
[TBL] [Abstract][Full Text] [Related]
15. Glycosylation of α-dystroglycan: O-mannosylation influences the subsequent addition of GalNAc by UDP-GalNAc polypeptide N-acetylgalactosaminyltransferases.
Tran DT; Lim JM; Liu M; Stalnaker SH; Wells L; Ten Hagen KG; Live D
J Biol Chem; 2012 Jun; 287(25):20967-74. PubMed ID: 22549772
[TBL] [Abstract][Full Text] [Related]
16. LARGE can functionally bypass alpha-dystroglycan glycosylation defects in distinct congenital muscular dystrophies.
Barresi R; Michele DE; Kanagawa M; Harper HA; Dovico SA; Satz JS; Moore SA; Zhang W; Schachter H; Dumanski JP; Cohn RD; Nishino I; Campbell KP
Nat Med; 2004 Jul; 10(7):696-703. PubMed ID: 15184894
[TBL] [Abstract][Full Text] [Related]
17. O-mannosyl phosphorylation of alpha-dystroglycan is required for laminin binding.
Yoshida-Moriguchi T; Yu L; Stalnaker SH; Davis S; Kunz S; Madson M; Oldstone MB; Schachter H; Wells L; Campbell KP
Science; 2010 Jan; 327(5961):88-92. PubMed ID: 20044576
[TBL] [Abstract][Full Text] [Related]
18. Deficiency of alpha-dystroglycan in muscle-eye-brain disease.
Kano H; Kobayashi K; Herrmann R; Tachikawa M; Manya H; Nishino I; Nonaka I; Straub V; Talim B; Voit T; Topaloglu H; Endo T; Yoshikawa H; Toda T
Biochem Biophys Res Commun; 2002 Mar; 291(5):1283-6. PubMed ID: 11883957
[TBL] [Abstract][Full Text] [Related]
19. Residual laminin-binding activity and enhanced dystroglycan glycosylation by LARGE in novel model mice to dystroglycanopathy.
Kanagawa M; Nishimoto A; Chiyonobu T; Takeda S; Miyagoe-Suzuki Y; Wang F; Fujikake N; Taniguchi M; Lu Z; Tachikawa M; Nagai Y; Tashiro F; Miyazaki J; Tajima Y; Takeda S; Endo T; Kobayashi K; Campbell KP; Toda T
Hum Mol Genet; 2009 Feb; 18(4):621-31. PubMed ID: 19017726
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the LARGE family of putative glycosyltransferases associated with dystroglycanopathies.
Grewal PK; McLaughlan JM; Moore CJ; Browning CA; Hewitt JE
Glycobiology; 2005 Oct; 15(10):912-23. PubMed ID: 15958417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
